Category: News
University of Missouri Research Reactor joins Nuclear Medicine Europe
Mizzou’s collaboration will strengthen global radiopharmaceutical and imaging supply.
Pioneering progress in cancer treatments
From its research reactor to revolutionary therapies, Mizzou’s innovations are shaping the future of precision medicine.
Michael Hoehn II named inaugural program director of NextGen MURR
Hoehn will lead Mizzou’s transformational initiative to build a new state-of-the-art research reactor that will expand medical isotope production.
Making a positive impact
When University of Missouri senior Grace Liles enrolled at Mizzou, one of the world’s leading research institutions, she joined the chemistry fraternity Alpha Chi Sigma.
MITC administratively realigns under MU Research Reactor
The change will allow for consistent staff training, a cohesive and vibrant safety culture and dedicated facility support.
Innovative yttrium-90 radioisotopes revolutionize liver cancer treatment
Yttrium-90 radioisotopes produced at the University of Missouri Research Reactor are extending and improving the lives of patients with liver cancer.
Adding a radioisotope to the toolkit for saving lives
A pair of University of Missouri researchers study terbium-161 with the hope that one day it could be the next major radioisotope produced to treat cancer.
MU Health Care pilots breakthrough treatment for prostate cancer
Treatment uses radioisotopes produced in the University of Missouri Research Reactor.
MU Research Reactor announces commercial shipments of breakthrough radioisotope for cancer treatment
The University of Missouri Research Reactor (MURR) is the only U.S. supplier of the radioisotope, produced using a propriety process developed at MURR.
Tiny atoms, big impact: How the MU Research Reactor is saving and improving lives in Missouri and around the globe
NextGen MURR initiative will expand the University of Missouri’s capacity to produce medical isotopes that will be used in advanced cancer treatments for decades to come.